Page last updated: 2024-08-17

spironolactone and trelstar

spironolactone has been researched along with trelstar in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Barnes, KM; Cutler, GB; Jones, J; Laue, L1
Barnes, KM; Cutler, GB; Hill, SC; Jones, J; Leschek, EW1
Adami, S; Castello, R; Gatti, D; Moghetti, P; Muggeo, M; Negri, C; Rossini, M; Tosi, F; Zamberlan, N1
Barnes, KM; Bryant, JC; Cutler, GB; Flor, AC; Jones, JV; Leschek, EW1
Chen, R; Lin, X; Yang, X; Yuan, X; Zhang, Y1

Trials

3 trial(s) available for spironolactone and trelstar

ArticleYear
Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 76, Issue:1

    Topics: Age Determination by Skeleton; Body Height; Bone Development; Child; Child, Preschool; Drug Therapy, Combination; Follicle Stimulating Hormone; Follow-Up Studies; Gonadotropin-Releasing Hormone; Growth; Humans; Luteinizing Hormone; Male; Pilot Projects; Puberty, Precocious; Spironolactone; Testolactone; Testosterone; Triptorelin Pamoate

1993
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:4

    Topics: Adult; Bone and Bones; Bone Density; Bone Resorption; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone; Triptorelin Pamoate

1999
Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
    The Journal of pediatrics, 2017, Volume: 190

    Topics: Adult; Anastrozole; Androgen Antagonists; Aromatase Inhibitors; Body Height; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Nitriles; Puberty, Precocious; Spironolactone; Testolactone; Treatment Outcome; Triazoles; Triptorelin Pamoate

2017

Other Studies

2 other study(ies) available for spironolactone and trelstar

ArticleYear
Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:1

    Topics: Adolescent; Bone Development; Child; Child, Preschool; Gonadotropin-Releasing Hormone; Growth; Humans; Male; Puberty, Precocious; Spironolactone; Testolactone; Testosterone; Triptorelin Pamoate

1999
Long-Term Treatment With Letrozole in a Boy With Familial Male-Limited Precocious Puberty.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Adult; Child; Child, Preschool; Humans; Letrozole; Male; Puberty, Precocious; Spironolactone; Triptorelin Pamoate

2022